Herceptin Medications
Links shared publicly online about this topic
Routine Testing Would Improve Herceptin Use in Breast Cancer
health.msn.com — “Routine Testing Would Improve Herceptin Use in Breast Cancer” View full resource at health.msn.com
Most Recently Shared on September 14, 2009 at 3:49 pm By:
Routine Testing Would Improve Herceptin Use in Breast Cancer http://bit.ly/3Lpcg3
Medical News: SABCS: Curtain-Raiser -- Data on Bisphosphonates, Herceptin Awaited - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Bisphosphonates will be a headlining act at the San Antonio Breast Cancer Symposium this year, with further refinements for trastuzumab (Herceptin) use expected as well.” View full resource at medpagetoday.com
Most Recently Shared on December 10, 2009 at 12:35 am By:
SABCS: Data on Bisphosphonates, Herceptin Awaited http://ow.ly/167VPQ
Medical News: Lasting Benefits Seen for Adjuvant Herceptin - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “Breast cancer patients had significantly better disease-free survival four years after treatment with trastuzumab (Herceptin), according to long-term follow-up from a large randomized trial.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 5:28 pm By:
Lasting Benefits Seen for Adjuvant Herceptin (CME/CE) http://bit.ly/eg5Djd
Medical News: Lasting Benefits Seen for Adjuvant Herceptin - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “Breast cancer patients had significantly better disease-free survival four years after treatment with trastuzumab (Herceptin), according to long-term follow-up from a large randomized trial.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 6:18 pm By:
Lasting Benefits Seen for Adjuvant Herceptin (CME/CE) http://bit.ly/hJZUli
Medical News: ASCO: Everolimus Plus Herceptin Promising in Metastatic Breast Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Adding the targeted agent everolimus (Afinitor) to therapy for women with metastatic breast cancer resistant to trastuzumab (Herceptin) results in clinical benefit for more than a third of” View full resource at medpagetoday.com
Most Recently Shared on June 6, 2010 at 12:19 pm By:
ASCO: Everolimus Plus Herceptin Promising in Metastatic Breast Cancer http://bit.ly/cv4zD3
Medical News: Herceptin Heart Risks Clarified for Older Patients - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “Older breast cancer patients with heart disease or diabetes have a significantly increased risk of cardiotoxicity when treated with trastuzumab, according to data from a single-center chart review.” View full resource at medpagetoday.com
Most Recently Shared on August 10, 2011 at 1:35 pm By:
Herceptin Heart Risks Clarified for Older Patients (CME/CE) http://bit.ly/nLvDKf
Routine Testing Would Improve Herceptin Use in Breast Cancer - Drugs.com MedNews
drugs.com — “New research suggests that the anti-breast cancer drug trastuzumab, also known as Herceptin, isn t reaching its full potential. Many patients aren t receiving t” View full resource at drugs.com
Most Recently Shared on September 14, 2009 at 8:49 pm By:
Routine Testing Would Improve Herceptin Use in Breast Cancer - http://bit.ly/8htK6
Herceptin Now Shown To Significantly Prolong The Lives Of Patients With HER2-positive Advanced Stomach Cancer
medicalnewstoday.com — “Roche announced results from a major international study which show that adding Herceptin (trastuzumab) to standard chemotherapy significantly prolongs lives of patients with HER2-positive stomach” View full resource at medicalnewstoday.com
Most Recently Shared on March 19, 2009 at 9:18 pm By:
John L LeRoy Jr MD Surgeon, Plastic Surgeon, Physician, and Doctor
http://bit.ly/t8vN Herceptin Now Shown To Significantly Prolong The Lives Of Patients With HER2-positive Advanced Stomach Cancer
Routine Testing Would Improve Herceptin Use in Breast Cancer - myOptumHealth
myoptumhealth.com — “Read the news article Routine Testing Would Improve Herceptin Use in Breast Cancer at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on September 14, 2009 at 5:37 pm By:
Routine Testing Would Improve Herceptin Use in Breast Cancer: Targeted drug therapy often doesn't reach the righ.. http://bit.ly/3IB1Zk
Regarding the medications you took, Carboplatin, Docetaxel, tamoxifen, & Herceptin. What do you wish your physician would have shared about these medications?
talkabouthealth.com — “I wish that my physician (who is no longer my physician) had explained the relationship between steroids (the reason for pre-medicating with steroids) and the c” View full resource at talkabouthealth.com
Most Recently Shared on September 22, 2011 at 8:47 pm By:
Regarding meds taken Carboplatin, Docetaxel. What do you wish physician shared abot them? grt ans @cancerfree2b http://t.co/ZXSc8QXZ #bcsm
Medical News: More Benefits of Targeting HER2 in Breast Cancer - in Oncology, Breast Cancer from MedPage Today
medpagetoday.com — “The addition of trastuzumab (Herceptin) before and after surgery significantly improved event-free survival compared with neoadjuvant chemotherapy alone in women with HER2-positive locally advanced or” View full resource at medpagetoday.com
Most Recently Shared on January 29, 2010 at 6:09 pm By:
More Benefits of Targeting HER2 in Breast Cancer (CME/CE) The addition of trastuzumab (Herceptin) before and after su.. http://bit.ly/cxHdKq
Medical News: ASCO Breast: Trastuzumab Called Effective in Low-Risk Breast Cancer - in Meeting Coverage, ASCO Breast from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Trastuzumab (Herceptin) appears to improve outcomes even for women at low risk of recurrence due to small, node-negative, HER2-positive breast cancer, researchers found in a retrospec” View full resource at medpagetoday.com
Most Recently Shared on October 12, 2009 at 12:15 pm By:
Trastuzumab (Herceptin) may improve outcomes even for women at low risk of recurrence of HER2-positive breast cancer. http://bit.ly/4w7Xgt
Medical News: SABCS: Trastuzumab Dosing During Chemo Vindicated - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Delaying trastuzumab (Herceptin) until after chemotherapy may impair outcomes for women with breast cancer, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on December 13, 2009 at 10:07 pm By:
SABCS: Trastuzumab Dosing During Chemo Vindicated (CME/CE) SAN ANTONIO (MedPage Today) -- Delaying trastuzumab (Herce.. http://bit.ly/7vyEPq
Medical News: ESMO: Obesity Does Not Interfere with Trastuzumab Response - in Meeting Coverage, ESMO from MedPage Today
medpagetoday.com — “MILAN -- Obesity is known to be a risk factor for breast cancer and death in postmenopausal women -- but a small study found that obesity does not seem to hamper the response to trastuzumab (Herceptin” View full resource at medpagetoday.com
Most Recently Shared on October 11, 2010 at 12:27 am By:
Drugs and Devices OW OW Health
ESMO: Obesity Does Not Interfere with Trastuzumab Response: MILAN -- Obesity is known to be a risk factor for... http://bit.ly/cBMMRS #drug
Medical News: AACR: Radiolabeled Trastuzumab Tracks Disease Progression - in Meeting Coverage, AACR from MedPage Today
medpagetoday.com — “WASHINGTON -- Scientists here reported that tagging a copper isotope to conjugated trastuzumab (Herceptin) might allow doctors to monitor the progress a drug is having in combating cancer.” View full resource at medpagetoday.com
Most Recently Shared on April 22, 2010 at 5:53 pm By:
AACR: Radiolabeled Trastuzumab Tracks Disease Progression (CME/CE) http://bit.ly/aUs6sF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
msn
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
Advertisement
